top of page
HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
2022 Rome Action Plan on Paediatric HIV & TB
Laurus Labs
Laurus Labs commits to:
240. Collaborating with regulators and clinicians to obtain data on the ease of administration of oral films in neonates and the paediatric population by 2024.
241. Expanding the oral film technology to other HIV products as well as TB and malaria.
242. Allocating resources to develop DRV and TAF containing FDCs for the paediatric use beginning Q2 2023.
-
bottom of page